Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Opioids | Research

Contextualizing medications for opioid use disorder and peer support service provision in the probation system with implementation science

Authors: Augustine W. Kang, Amelia Bailey, Siena Napoleon, Rosemarie Martin

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Medications for opioid use disorder (MOUD) is an evidence-based approach that reduces opioid-related mortality, particularly among criminal legal-involved persons who are at increased risk of adverse outcomes related to OUD. Implementing evidence-based approaches in the context of probation settings requires an in-depth understanding of specific contexts to improve intervention efficacy and effectiveness. Here, we use the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework to understand implementation contexts for MOUD provision in the probation setting.

Methods

In-depth individual interviews were conducted with key programmatic stakeholders (treatment providers and probation staff involved in service provision for people on probation). The study examined stakeholder perspectives regarding MOUD and Peer Support Service (PSS) implementation among people who are involved in community supervision. Deductive and inductive thematic analysis was conducted, and subsequently the codes, subcodes, and themes were mapped onto the EPIS framework to better understand implementation contexts.

Results

We deduced key inner, outer, and bridging contexts that shape treatment service provision for individuals with OUD who are on probation. Inner contexts include a strong organizational climate that supports MOUD implementation and enthusiasm for peer support services. Outer contexts include difficulty navigating insurance among providers, treatment costs, and systemic stigma towards MOUD. Bridging contexts include a lack of collaboration/communication between relevant agencies (e.g., probation and courts).

Conclusions

Findings indicate the implementation is complex and requires a coordinated effort between correctional systems, probation agencies, and community-based treatment providers.
Literature
1.
go back to reference Pizzicato LN, Drake R, Domer-Shank R, Johnson CC, Viner KM. Beyond the walls: risk factors for overdose mortality following release from the Philadelphia Department of Prisons. Drug Alcohol Depend. 2018;189:108–15.CrossRefPubMed Pizzicato LN, Drake R, Domer-Shank R, Johnson CC, Viner KM. Beyond the walls: risk factors for overdose mortality following release from the Philadelphia Department of Prisons. Drug Alcohol Depend. 2018;189:108–15.CrossRefPubMed
2.
go back to reference Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, et al. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release. Drug Alcohol Depend. 2018;184:57–63.CrossRefPubMedPubMedCentral Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, et al. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release. Drug Alcohol Depend. 2018;184:57–63.CrossRefPubMedPubMedCentral
3.
go back to reference Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B. Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review. PLoS Med. 2019;16(12):e1003002.CrossRefPubMedPubMedCentral Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B. Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review. PLoS Med. 2019;16(12):e1003002.CrossRefPubMedPubMedCentral
5.
go back to reference Krawczyk N, Picher CE, Feder KA, Saloner B. Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Aff. 2017;36(12):2046–53.CrossRef Krawczyk N, Picher CE, Feder KA, Saloner B. Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Aff. 2017;36(12):2046–53.CrossRef
6.
go back to reference Grella CE, Ostile E, Scott CK, Dennis M, Carnavale J. A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. Int J Drug Policy. 2020;81:102768.CrossRefPubMedPubMedCentral Grella CE, Ostile E, Scott CK, Dennis M, Carnavale J. A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system. Int J Drug Policy. 2020;81:102768.CrossRefPubMedPubMedCentral
7.
go back to reference McElrath K. Medication-assisted treatment for opioid addiction in the United States: Critique and commentary. Subst Use Misuse. 2018;53(2):334–43.CrossRefPubMed McElrath K. Medication-assisted treatment for opioid addiction in the United States: Critique and commentary. Subst Use Misuse. 2018;53(2):334–43.CrossRefPubMed
8.
go back to reference Gormley MA, Pericot-Valverde I, Diaz L, Coleman A, Lancaster J, Ortiz E et al. Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: a systematic review. Drug Alcohol Depend. 2021;229(Pt B):109123. Gormley MA, Pericot-Valverde I, Diaz L, Coleman A, Lancaster J, Ortiz E et al. Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: a systematic review. Drug Alcohol Depend. 2021;229(Pt B):109123.
9.
go back to reference Ray B, Watson DP, Xu H, Salyers MP, Victor G, Sightes E, et al. Peer recovery services for persons returning from prison: pilot randomized clinical trial investigation of SUPPORT. J Subst Abuse Treat. 2021;126:108339.CrossRefPubMedPubMedCentral Ray B, Watson DP, Xu H, Salyers MP, Victor G, Sightes E, et al. Peer recovery services for persons returning from prison: pilot randomized clinical trial investigation of SUPPORT. J Subst Abuse Treat. 2021;126:108339.CrossRefPubMedPubMedCentral
10.
go back to reference Reingle Gonzalez JM, Rana RE, Jetelina KK, Roberts MH. The value of lived experience with the criminal justice system: a qualitative study of peer re-entry specialists. Int J Offender Ther Comp Criminol. 2019;63(10):1861–75.CrossRefPubMed Reingle Gonzalez JM, Rana RE, Jetelina KK, Roberts MH. The value of lived experience with the criminal justice system: a qualitative study of peer re-entry specialists. Int J Offender Ther Comp Criminol. 2019;63(10):1861–75.CrossRefPubMed
11.
go back to reference Moullin JC, Dickson KS, Stadnick NA, Rabin B, Aarons GA. Systematic review of the Exploration, Preparation, implementation, sustainment (EPIS) framework. Implement Sci. 2019;14(1):1.CrossRefPubMedPubMedCentral Moullin JC, Dickson KS, Stadnick NA, Rabin B, Aarons GA. Systematic review of the Exploration, Preparation, implementation, sustainment (EPIS) framework. Implement Sci. 2019;14(1):1.CrossRefPubMedPubMedCentral
12.
go back to reference Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4–23.CrossRefPubMed Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4–23.CrossRefPubMed
13.
go back to reference Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, et al. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022;109:103823.CrossRefPubMedPubMedCentral Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, et al. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022;109:103823.CrossRefPubMedPubMedCentral
14.
go back to reference Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: a qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022;234:109394.CrossRefPubMedPubMedCentral Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: a qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022;234:109394.CrossRefPubMedPubMedCentral
15.
go back to reference Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD et al. Medication for opioid use disorder treatment continuity post-release from jail: a qualitative study with community-based treatment providers. Int J Drug Policy. 2022:103803. Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD et al. Medication for opioid use disorder treatment continuity post-release from jail: a qualitative study with community-based treatment providers. Int J Drug Policy. 2022:103803.
16.
go back to reference QSR International Pty Ltd. NVivo (Version 12). 2018. QSR International Pty Ltd. NVivo (Version 12). 2018.
17.
go back to reference Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters. Addiction. 2021;116(12):3473–81.CrossRefPubMed Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters. Addiction. 2021;116(12):3473–81.CrossRefPubMed
18.
go back to reference Kaplowitz E, Truong AQ, Berk J, Martin RA, Clarke JG, Wieck M, et al. Treatment preference for opioid use disorder among people who are incarcerated. J Subst Abuse Treat. 2022;137:108690.CrossRefPubMed Kaplowitz E, Truong AQ, Berk J, Martin RA, Clarke JG, Wieck M, et al. Treatment preference for opioid use disorder among people who are incarcerated. J Subst Abuse Treat. 2022;137:108690.CrossRefPubMed
19.
go back to reference Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146.CrossRefPubMedPubMedCentral Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146.CrossRefPubMedPubMedCentral
Metadata
Title
Contextualizing medications for opioid use disorder and peer support service provision in the probation system with implementation science
Authors
Augustine W. Kang
Amelia Bailey
Siena Napoleon
Rosemarie Martin
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18133-5

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue